
Natalie Willis
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
Jul 29, 2026
AJP Podcast: ‘Obviously there is some trepidation out there’
1:00
1:11
1:17
1:23
1:39
25:37

Carlene McMaughHOST
So Natalie, could you please walk us through what's actually changing in the new QSPP framework? Because there's a lot of noise and not a lot of clarity in the sector right now.

Natalie WillisGUEST
You can divide what we're- what we've changed into two major themes: the what and the how.

Natalie WillisGUEST
So the- the what we've changed, um, uh, is around clinical governance and patient engagement.

Natalie WillisGUEST
So they're the two things that are not in the current program, uh, that is going to be the most challenging for community pharmacists because this is areas that they haven't really delved into in any great depth before.

Natalie WillisGUEST
And- and they're already doing this in- in a way, uh, in their pharmacies, but we're just providing, uh...
24 MINS LATER

Carlene McMaughHOST
So Natalie, can I ask you, what do pharmacists have to do now? So if there's any pharmacists that have not been involved in the process so far, what advice do you have for them?